Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.

Nowak DG, Katsenelson KC, Watrud KE, Chen M, Mathew G, D'Andrea VD, Lee MF, Swamynathan MM, Casanova-Salas I, Jibilian MC, Buckholtz CL, Ambrico AJ, Pan CH, Wilkinson JE, Newton AC, Trotman LC.

J Cell Biol. 2019 May 15. pii: jcb.201902048. doi: 10.1083/jcb.201902048. [Epub ahead of print]

PMID:
31092557
2.

LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells.

Yokdang N, Hatakeyama J, Wald JH, Simion C, Tellez JD, Chang DZ, Swamynathan MM, Chen M, Murphy WJ, Carraway Iii KL, Sweeney C.

Oncogene. 2016 Jun 2;35(22):2932-47. doi: 10.1038/onc.2015.345. Epub 2015 Sep 21.

Supplemental Content

Loading ...
Support Center